Corvus Pharmaceuticals (CRVS) Interest & Investment Income (2015 - 2026)
Corvus Pharmaceuticals (CRVS) recorded quarterly Interest & Investment Income of $1.8 million in Q1 2026, up 195.85% quarter-over-quarter from $603000.0 in Q4 2025, and up 239.81% on a YoY basis from $525000.0 in Q1 2025.
Corvus Pharmaceuticals (CRVS) Interest & Investment Income (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 239.81% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $3.8 million (up 85.15% YoY), while the FY2025 annual figure was $2.5 million, up 37.34% from the prior year.
- Interest & Investment Income was $1.8 million for Q1 2026 at Corvus Pharmaceuticals, up from $603000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.8 million in Q1 2026 to a low of $316000.0 in Q1 2024.
- Historically, Interest & Investment Income has averaged $679222.2 across 3 years, with a median of $566000.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income rose 18.7% in 2025, then jumped 239.81% in 2026.
- A 3-year view of Interest & Investment Income shows it stood at $508000.0 in 2024, then rose by 18.7% to $603000.0 in 2025, then jumped by 195.85% to $1.8 million in 2026.
- The last three Interest & Investment Income figures came in at $1.8 million (Q1 2026), $603000.0 (Q4 2025), and $738000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Corvus Pharmaceuticals | 1.00 Bn | 766.75 Mn | - | 1.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 603,000.00 |
| Sep 30, 2025 | 738,000.00 |
| Jun 30, 2025 | 639,000.00 |
| Mar 31, 2025 | 525,000.00 |
| Dec 31, 2024 | 508,000.00 |
| Sep 30, 2024 | 566,000.00 |
| Jun 30, 2024 | 434,000.00 |
| Mar 31, 2024 | 316,000.00 |
| Mar 31, 2018 | 343,000.00 |
| Sep 30, 2017 | 227,000.00 |
| Jun 30, 2017 | 193,000.00 |
| Mar 31, 2017 | 181,000.00 |
| Sep 30, 2016 | 179,000.00 |
| Jun 30, 2016 | 180,000.00 |
| Mar 31, 2016 | 79,000.00 |
| Mar 31, 2015 | 1,000.00 |